Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2from the Central American coral snake,Micrurus nigrocinctus.
Snakebite envenomings represent a neglected public health issue in many parts of the rural tropical world. Animal-derived antivenoms have existed for more than a hundred years and are effective in neutralizing snake venom toxins when timely administered. However, the low immunogenicity of many small but potent snake venom toxins represents a challenge for obtaining a balanced immune response against the medically relevant components of the venom. Here, we employ high-throughput sequencing of the immunoglobulin (Ig) transcriptome of mice immunized with a three-finger toxin and a phospholipase A2from the venom of the Central American coral snake,Micrurus nigrocinctus.Although exploratory in nature, our indicate results showed that only low frequencies of mRNA encoding IgG isotypes, the most relevant isotype for therapeutic purposes, were present in splenocytes of five mice immunized with 6 doses of the two types of toxins over 90 days. Furthermore, analysis of Ig heavy chain transcripts showed that no particular combination of variable (V) and joining (J) gene segments had been selected in the immunization process, as would be expected after a strong humoral immune response to a single antigen. Combined with the titration of toxin-specific antibodies in the sera of immunized mice, these data support the low immunogenicity of three-finger toxins and phospholipases A2found inM. nigrocinctusvenoms, and highlight the need for future studies analyzing the complexity of antibody responses to toxins at the molecular level.
Department of Biotechnology and Biomedicine, Technical University of Denmark , Kgs. Lyngby , Denmark.
Andreas H
AH
Laustsen
Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs. Lyngby, Denmark; Department of Bio and Health Informatics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Mikael
M
Engmark
Juno Therapeutics, Seattle, WA, United States of America; AbVitro, Boston, MA, United States of America.
Christopher
C
Clouser
Finch Therapeutics , Somerville , MA , United States of America.
Sonia
S
Timberlake
Juno Therapeutics, Seattle, WA, United States of America; AbVitro, Boston, MA, United States of America.
Francois
F
Vigneault
Instituto Clodomiro Picado, Universidad de Costa Rica , San José , Costa Rica.
José María
JM
Gutiérrez
Instituto Clodomiro Picado, Universidad de Costa Rica , San José , Costa Rica.
Bruno
B
Lomonte
Antibodies; Antibody isotyping; Antivenom; Coral snake; High-throughput sequencing; Micrurus nigrocinctus; Murine immune response; Toxins; Transcriptomics; Venom